Once CRPC lines were established, they were further characterized on androgen responsiveness and expression of AR, AR target genes, and a panel of genes that have previously been described as drivers of castration resistance and resistance to second-line hormonal agents in PCa. The gene discussed is AR; the disease is posterior cortical atrophy.